Management Team

Network Coordination

• 

  Ansgar W. Lohse

  University Medical Centre Hamburg-Eppendorf, Germany

Paediatric lead

• 

  Ekkehard Sturm

  Eberhard Karls University Tübingen

Deputy coordinator

• 

  Marcial Sebode

  University Medical Centre Hamburg-Eppendorf, Germany

Pillar Leads

• 

  Joost P.H. Drenth

  Radboud University Medical Center Nijmegen, Netherlands

• 

  Tom Hemming Karlsen

  Oslo University Hospital, Norway

• 

  Ekkehard Sturm

  Eberhard Karls University Tübingen

Representatives of the hepatology societies (EASL & ESPGHAN)

• 

  Maria Reig

  Hospital Clínic i Provincial de Barcelona, Spain

  EASL Representative

• 

  Ekkehard Sturm

  Eberhard Karls University Tübingen

  ESPGHAN Representative

Patient Leads

• 

  Alison Taylor

  Paediatric Patient Lead

  Children´s Liver Disease Foundation, UK

• 

  Martine Walmsley

  PSC support, UK; EASL Policy and Public Health Committee

• 

  José Willemse

  Adult Patient Lead

  Nederlandse Leverpatienten Vereniging, Netherlands

Network Project Management

• 

  Aileen Franke

  University Medical Centre Hamburg-Eppendorf, Germany

• 

  Elaine Hussey

  University Medical Centre Hamburg-Eppendorf, Germany

• 

  Laura Ruhkopf

  University Medical Centre Hamburg-Eppendorf, Germany

Working Packages - Leads

Registry

• 

  Christoph Schramm

  University Medical Centre Hamburg-Eppendorf, Germany

CPMS

• 

  Marcial Sebode

  University Medical Centre Hamburg-Eppendorf, Germany

Quality of Life

• 

  Piotr Milkiewicz

  Medical University of Warsaw Hospital, Poland

Guidelines

• 

  Juan Carlos García-Pagán

  Hospital Clínic i Provincial de Barcelona, Spain

• 

  Aurélie Plessier

  Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, France

Training

• 

  Juan Carlos García-Pagán

  Hospital Clínic i Provincial de Barcelona, Spain

Research

• 

  Mike Jackson

  iXscient, UK

• 

  Christoph Schramm

  University Medical Centre Hamburg-Eppendorf, Germany

Disease Working Groups - Leads

Pillar 1: Autoimmune Liver Disease (AILD)

• 

  Tom Hemming Karlsen

  Oslo University Hospital, Norway

PBC

• 

  Pietro Invernizzi

  ASST Monza, Ospedale San Gerardo, Italy

AIH

• 

  Marcial Sebode

  University Medical Centre Hamburg-Eppendorf, Germany

PSC

• 

  Annika Bergquist

  Karolinska University Hospital Stockholm, Sweden

Pillar 2: Metabolic, Biliary Atresia & Related Disease

• 

  Ekkehard Sturm

  Eberhard Karls University Tübingen

Genetic Cholestatic Disease

• 

  Emmanuel Gonzales

  Hôpital Bicêtre, Assistance Publique – Hôpitaux de Paris, France

• 

  Henkjan J. Verkade

  University Medical Center Groningen, Netherlands

Biliary Atresia

• 

  Björn Fischler

  Karolinska University Hospital Stockholm, Sweden

• 

  Claus Petersen

  Hannover Medical School, Germany

AATD

• 

  Pavel Strnad

  University Hospital Aachen, Germany

Acute Liver Failure

• 

  Dominic Lenz

  Heidelberg University Hospital, Germany

Pillar 3: Structural Liver Disease

• 

  Joost P.H. Drenth

  Radboud University Medical Center Nijmegen, Netherlands

PLD

• 

  Joost P.H. Drenth

  Radboud University Medical Center Nijmegen, Netherlands

Vascular Liver Disease

• 

  Aurélie Plessier

  Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, France

Biliary Malformations

• 

  Joost P.H. Drenth

  Radboud University Medical Center Nijmegen, Netherlands

Wilson's Disease

• 

  Alain Lachaux

  Hôpital Femme Mère Enfant du CHU de Lyon, France

Rare Liver Tumours Lead

• 

  Henning Wege

  University Medical Centre Hamburg-Eppendorf, Germany

Liver Disease in Pregnancy Leads

• 

  Michael A Heneghan

  King’s College London, UK

• 

  Catherine Williamson

  King’s College London, UK